Advertisement

BPH/LUTS

Efficacy and tolerability of doxazosin gastro-intestinal therapeutic system versus tamsulosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: A systematic review and meta-analysis.

Aug 23, 2021

Alpha1-adrenoceptor antagonists (α1-blockers) are first-line drugs for the treatment of lower urinary tract symptoms associated with benign prostate hyperplasia (BPH). Doxazosin gastrointestinal ther...

Prostatic Artery Embolization: Indications, Preparation, Techniques, Imaging Evaluation, Reporting, and Complications.

Aug 23, 2021

Benign prostatic hyperplasia (BPH) is a noncancerous growth of the transitional zone of the prostate, which surrounds the prostatic urethra. Consequently, it can cause lower urinary tract symptoms (LU...

Systematic review and meta-analysis identify significant relationships between clinical anxiety and lower urinary tract symptoms.

Aug 19, 2021

Lower urinary tract symptoms (LUTS), such as voiding symptoms, overactive bladder, and interstitial cystitis, and anxiety disorders are often comorbid conditions in patients. However, the existing evi...

Seven-membered Cyclic Potassium Diamidoalumanyls.

Aug 19, 2021

The seven-membered cyclic potassium alumanyl species, [{SiN Mes }AlK] 2 [{SiN Mes } = {CH 2 SiMe 2 N(Mes)} 2 ; Mes = 2,4,6-Me 3 C 6 H 2 ], which adopts a dimeric structure supported by flanking K-aryl...

Urinary adenosine triphosphate and nitric oxide levels in patients with underactive bladder: a preliminary study.

Aug 19, 2021

Various in vitro and in vivo animal studies have shown that adenosine triphosphate (ATP) has a stimulatory role and nitric oxide (NO) has an inhibitory role in modulating bladder contractility. Howeve...

Open simple prostatectomy and robotic simple prostatectomy for large benign prostatic hyperplasia: Comparison of safety and efficacy.

Aug 16, 2021

To compare the safety and efficacy of open simple prostatectomy (OSP) and robotic simple prostatectomy (RSP) for the treatment of large benign prostatic hyperplasia (BPH).We retrospectively reviewed t...

Scandium Reduced Arene Complex: Protonation and Reaction with Azobenzene.

Aug 16, 2021

Reactivity of the reduced anthracene complex of scandium [Li(thf) 3 ][Sc{N( t Bu)Xy} 2 (anth)] ( 2-anth-Li ) (Xy = 3,5-Me 2 C 6 H 3 ; anth = C 14 H 10 2- , thf = tetrahydrofuran) toward Brönsted acid...

Evaluation of pedometer use in men with lower urinary tract symptoms: a randomized clinical trial.

Aug 16, 2021

To assess the effect of a pedometer use in men aged between 50 and 59 years presenting lower urinary tract symptoms (LUTS).A single-center, not blind clinical trial with two parallel groups and equal...

The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).

Aug 12, 2021

Many men receive 5-alpha reductase inhibitors (5ARIs) for ongoing treatment of benign prostatic hyperplasia (BPH). The increased risk of cardiovascular complications with 5ARIs has been documented in ...

Preserving ejaculatory function in young patients with lower urinary tract symptoms: medium- to long-term follow-up of prostatic urethral lift at a single center.

Aug 12, 2021

Prostatic urethral lift (Urolift™) is a minimally invasive technique to treat male lower urinary tract symptoms (LUTSs) due to benign prostatic hyperplasia (BPH). The aim of the present study w...

Robotic-Assisted vs. Open Simple Prostatectomy for Large Prostates: A Meta-Analysis.

Aug 09, 2021

To compare the efficacy and safety of robotic-assisted simple prostatectomy and open simple prostatectomy for large benign prostatic hyperplasia. We systematically searched the Cochrane Library, Pub...

Curcumin attenuates prostatic hyperplasia caused by inflammation up-regulation of bone morphogenetic protein and activin membrane-bound inhibitor.

Aug 09, 2021

Inflammation and epithelial-mesenchymal transition (EMT) play important roles in the occurrence and development of benign prostatic hyperplasia (BPH); curcumin exerts anti-proliferative, anti-inflamma...

The UroLift implant: mechanism behind rapid and durable relief from prostatic obstruction.

Aug 09, 2021

Benign prostatic hyperplasia (BPH) is an affliction of the aging male population that contributes to bothersome and disruptive lower urinary tract symptoms (LUTS). The UroLift® implant has been devel...

Spinal versus general anesthesia for Holmium laser enucleation of the prostate of high-risk patients - A propensity-score-matched-analysis.

Aug 05, 2021

To compare perioperative management and functional outcome of spinal anesthesia (SpA) to general anesthesia (GA) in high-risk patients treated for lower urinary tract symptoms (LUTS) with Holmium lase...

Effects of inflammatory prostatitis on the development and progression of benign prostatic hyperplasia: A literature review.

Aug 05, 2021

Benign prostatic hyperplasia is a major disease that affects the quality of life of middle-aged and older men. Although >70% of men aged >70 years have pathological benign prostatic hyperplasia...

Prostate interventions in patients with mild haemophilia: Safe and feasible.

Aug 05, 2021

To date, there is no specific recommendation or evaluation of the morbidity of prostate surgery in patients with haemophilia (PWH) although this surgery is common and at high risk of bleeding.To asses...

High Level of Phosphatidylcholines/Lysophosphatidylcholine Ratio in Urine is Associated with Prostate Cancer.

Aug 02, 2021

The altered levels of phospholipids (PLs) and lysophospholipids (LPLs) in prostate cancer (CaP) and benign tissues in our previous findings prompted us to explore PLs and LPLs as potential biomarkers ...

Global, Regional, and National Incidence and Year Lived with Disability for Benign Prostatic Hyperplasia from 1990 to 2019.

Aug 02, 2021

The objective of this study is to provide comprehensive and up-to-date estimates on the disease burden of BPH in 204 countries and territories between 1990 and 2019. Data about incidence, year lived w...

Prolieve® Transurethral Thermodilatation for treatment of Symptomatic Benign Prostatic Hyperplasia: 5-Year Results from a Prospective Multi-Center Trial.

Jul 29, 2021

Introduction & Objective Prolieve® transurethral thermodilatation (TUTD) is the only third-generation transurethral microwave thermotherapy (TUMT) device that incorporates balloon dilation/compre...

Urodynamic effects of prostatic urethral lift procedure for male voiding LUTS.

Jul 29, 2021

Primary objective is to investigate whether prostatic urethral lift (PUL) results in an improvement of urodynamic parameters that define bladder outlet obstruction (urethral resistance algorithm [URA]...

SUBSPECIALTIES

Advertisement